ALLMedicine™ Venous Thromboembolism Center

May 15th, 2022 - No matter the practice setting, physical therapists work with patients who are at risk for or who have a history of venous thromboembolism (VTE). In 2016, the first clinical practice guideline (CPG) addressing the physical therapist management of ...

May 14th, 2022 - Patients with active cancer have a 4-sevenfold increased risk for venous thromboembolism (VTE) especially during systematic anticancer treatment. Simultaneously, surgery is an additional risk factor. The Metaxas's Hospital THromboprophylaxis progr...

May 14th, 2022 - Venous thromboembolism (VTE) is a concern for patients with newly diagnosed multiple myeloma. We aimed to evaluate VTE incidence, risk factors and risk score. We performed a substudy of the 'Intergroupe Francophone du Myelome 2009' randomized cont...

May 14th, 2022 - Prior observational studies suggest rivaroxaban is safe and effective among patients with morbid obesity who suffered a venous thromboembolism (VTE) event, but existing data are more limited in the broader population of VTE patients with obesity. ...

May 14th, 2022 - Patients with COVID-19 infection are commonly reported to have an increased risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently being studied in randomized controlled trials and retrospective studies. There exis...

Nov 3rd, 2021 - COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care pr...

Sep 3rd, 2021 - COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care...

Jul 21st, 2021 - The goal of this study was to develop an approach that can be used where baseline risk estimates that are directly applicable to prioritized patient-important outcomes are not available from published studies. The McMaster University GRADE Centre ...

Feb 12th, 2021 - Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. These evidence-based guidelines of the American Society of Hematology (ASH...

Dec 2nd, 2020 - Venous thromboembolism (VTE) is a common cause of morbidity and mortality in women with gynecologic malignancies. This practice statement provides clinical data and overall quality of evidence regarding the use of direct oral anticoagulants (DOACs...

May 11th, 2022 - PRIMARY OBJECTIVE: I. Any episode of major bleeding including fatal bleeding or clinically relevant non-major bleeding. SECONDARY OBJECTIVES: I. The proportion of patients who experienced at least one such bleeding event within 6 months of beginni...

May 6th, 2022 - The purpose of the pilot PARTUM trial is to determine whether it is feasible to conduct a larger randomized controlled trial to determine whether low-dose aspirin is efficacious and safe at preventing postpartum venous thromboembolism (VTE) in wom...

May 2nd, 2022 - This will be a quantitative prospective cohort study conducted at the University of Texas Medical Branch (UTMB) Galveston and League City campuses. Candidates include subjects who will have elective colorectal surgery at UTMB. This study looks to ...

Apr 27th, 2022 - The objective of this study is to compare right ventricular dysfunction (RVD)dependent and independent prognostic models for short-term serious adverse events in pulmonary embolism (PE) patients. The target population is emergency department (ED) ...

Apr 26th, 2022 - Hospital acquired thrombosis describes blood clots that form in the legs and lungs after someone is treated in hospital. Clots in the leg can cause swelling, pain and other problems. If a clot in the leg travels to the lungs, it may be life threat...

May 12th, 2022 - Core Messages If no triggering event can be identified for a patient with deep vein thrombosis, an unknown cancer should be considered as a cause. Rosemary Poulose and L. Christian Napp, MD, et al from Hannover Medical School in Germany recalled t...

Apr 27th, 2022 - Venous thromboembolism (VTE) is common in patients with cancer and can increase the risk of dying, as well as interfering with treatment and increasing the cost of treatment. New findings suggest that patients with cancer who have non-O blood type...

Apr 25th, 2022 - Key clinical point: Adjuvant abemaciclib plus endocrine therapy (ET) showed a manageable and acceptable safety profile in patients with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-), high-risk, early breast canc.

Apr 7th, 2022 - The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways In a UK Biobank cohort, ambulatory patients with mild COVID-19 were 20 times more likely to develop venous thromboemboli...

Apr 2nd, 2022 - The antifibrinolytic tranexamic acid (TXA) reduced serious bleeding without a significant effect on major vascular outcomes in patients undergoing noncardiac surgery at risk for these complications in the POISE-3 trial. TXA cut the primary efficac...